Treatment characteristics of patients according to the admission SBP (mm Hg)
| Variable | Normal SBP (100–139) (n=4182) | Modestly elevated SBP (140–179) (n=2187) | Excessively elevated SBP (≥180) (n=222) | p Value |
|---|---|---|---|---|
| Reperfusion strategies | ||||
| Thrombolysis (n (%)) | 2252 (53.8) | 1101 (50.3) | 96 (43.2) | 0.001 |
| PCI (n (%)) | 517 (12.4) | 241 (11.0) | 15 (6.8) | 0.018 |
| Anticoagulants | ||||
| Heparin (or LMWH) (n (%)) | 3881 (92.8) | 1981 (90.6) | 197 (88.7) | 0.035 |
| Antiplatelet therapy | ||||
| Aspirin (n (%)) | 4028 (96.3) | 2107 (96.3) | 210 (94.6) | 0.408 |
| Clopidogrel (n (%)) | 1205 (28.8) | 605 (27.7) | 55 (24.8) | 0.310 |
| Other medications | ||||
| β Blocker (n (%)) | 2591 (62.0) | 1485 (67.9) | 152 (68.5) | <0.001 |
| ACEI (or ARB) (n (%)) | 2965 (70.9) | 1790 (81.8) | 194 (87.4) | <0.001 |
| Statins (n (%)) | 2999 (71.7) | 1621 (74.1) | 163 (73.4) | 0.118 |
| CCB (n (%)) | 499 (11.9) | 329 (15.0) | 50 (22.5) | <0.001 |
ACEI, ACE inhibitors; ARB, angiotensin receptors blockers; CCB, calcium channel blocker; LMWH, low molecular weight heparin; PCI, percutaneous coronary intervention; SBP, systolic blood pressure.